Dimensional Fund Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36.7K | Hold |
|
|||||
2025
Q1 | $18.3K | Hold |
|
|||||
2024
Q4 | $20.3K | Hold |
|
|||||
2024
Q3 | $36.6K | Hold |
|
|||||
2024
Q2 | $40.3K | Hold |
|
|||||
2024
Q1 | $59.9K | Hold |
|
|||||
2023
Q4 | $44.1K | Hold |
|
|||||
2023
Q3 | $47.7K | Hold |
|
|||||
2023
Q2 | $57K | Hold |
|
|||||
2023
Q1 | $60.7K | Sell |
|
|||||
2022
Q4 | $56 | Hold |
|
|||||
2022
Q3 | $55K | Sell |
|
|||||
2022
Q2 | $103K | Sell |
|
|||||
2022
Q1 | $198K | Hold |
|
|||||
2021
Q4 | $315K | Hold |
|
|||||
2021
Q3 | $324K | Hold |
|
|||||
2021
Q2 | $367K | Hold |
|
|||||
2021
Q1 | $302K | Buy |
|
|||||
2020
Q4 | $219K | Hold |
|
|||||
2020
Q3 | $116K | Sell |
|
|||||
2020
Q2 | $127K | Sell |
|
|||||
2020
Q1 | $125K | Hold |
|
|||||
2019
Q4 | $135K | Sell |
|
|||||
2019
Q3 | $152K | Hold |
|
|||||
2019
Q2 | $170K | Hold |
|
|||||
2019
Q1 | $203K | Sell |
|
|||||
2018
Q4 | $143K | Sell |
|
|||||
2018
Q3 | $368K | Hold |
|
|||||
2018
Q2 | $323K | Hold |
|
|||||
2018
Q1 | $422K | Hold |
|
|||||
2017
Q4 | $337K | Hold |
|
|||||
2017
Q3 | $445K | Buy |
|
|||||
2017
Q2 | $380K | Buy |
|